Anbio Biotechnology
$26.98
▲
0.58%
2026-04-21 08:26:00
www.anbio.com
NGM: NNNN
Explore Anbio Biotechnology stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.88 B
Current Price
$26.98
52W High / Low
$55.65 / $6.05
Stock P/E
380.56
Book Value
$0.63
Dividend Yield
—
ROCE
11.61%
ROE
27.05%
Face Value
—
EPS
$0.15
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
—
Beta
—
Debt / Equity
—
Current Ratio
344.31
Quick Ratio
344.31
Forward P/E
—
Price / Sales
137.56
Enterprise Value
$1.18 B
EV / EBITDA
—
EV / Revenue
136.18
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 2. | DENTSPLY SIRONA Inc. | $12.79 | — | $2.61 B | 5.5% | 6.17% | -36.43% | $17.18 / $9.85 | $6.71 |
| 3. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
| 4. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
| 5. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 6. | ResMed Inc. | $224.49 | 22.19 | $32.69 B | 1.06% | 23.58% | 25.68% | $293.81 / $202 | $43.39 |
| 7. | Hologic, Inc. | NOT FOUND | — | — | — | 9.77% | 10.86% | $76.07 / $51.9 | $23.51 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 8.65 M | 8.19 M | 6.71 M | 23.54 M |
| Operating Profit | 5.77 M | 2 M | 1.96 M | 10.2 M |
| Net Profit | 6.4 M | 2.37 M | 2.25 M | 10.01 M |
| EPS in Rs | 0.15 | 0.05 | 0.05 | 0.23 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 30.24 M | 18.92 M | 15.81 M | 13.96 M |
| Total Liabilities | 0.09 M | 1.73 M | 0.99 M | 1.41 M |
| Equity | 30.16 M | 17.19 M | 14.82 M | 12.55 M |
| Current Assets | 30.24 M | 18.53 M | 15.75 M | 13.94 M |
| Current Liabilities | 0.09 M | 1.73 M | 0.99 M | 1.41 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -6.74 M | 2.08 M | 0.9 M | 4.45 M |
| Investing CF | -4.2 M | 0.34 M | 1.73 M | -1.53 M |
| Financing CF | 6.95 M | -0.34 M | -0.04 M | 0 M |
| Free CF | -6.74 M | 2.08 M | 0.9 M | 4.45 M |
| Capex | — | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 21.95% | -71.49% | — | — |
| Earnings Growth % | 5.29% | -77.49% | — | — |
| Profit Margin % | 28.99% | 33.58% | 42.52% | — |
| Operating Margin % | 24.38% | 29.22% | 43.3% | — |
| Gross Margin % | 71.9% | 50.07% | 53.36% | — |
| EBITDA Margin % | 24.38% | 29.39% | 42.58% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.